Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug

Related Link: 

Pfizer has become the latest drugmaker taken to task for high prices after U.K. authorities hit the company with a record $107 million fine over the price of an anti-epilepsy drug.

Credit Suisse's Ambitions Take Another Knock

Related Link: 

Cuts to profit targets for Asia raise questions over the bank’s core trade.

The Promise and Peril of the Trump Trade

Related Link: 

Long-term interest rates have risen sharply on the view that President-elect Trump will deliver on his pledge to bolster the economy. That needn’t be a problem—unless he can’t follow through.

Banks Tease Bigger Dividends

Related Link: 

Comments by J.P. Morgan Chase chief James Dimon suggest banks could be poised to pay out more dividends.

Wearable Tech Looking Worse for Wear

Related Link: 

Slowing sales of wearable gadgets at Fitbit and Apple cast doubt on market’s ultimate potential.

Aging Population, Stagnant Productivity Challenge Donald Trump's Growth Plan

Related Link: 

President-elect Donald Trump and his emerging team are confident their proposed tax cuts and regulatory rollbacks will spark a dramatic upswing in economic growth. Two forces will make that tough: an aging population and stagnant productivity.

Beware Medicare Advantage Plans

Related Link: 

A recent report says many buyers are confused

Hensarling: GOP Wants to End Rules on Retirement Advice, Payday Loans

Related Link: 

Congressional Republicans hope to scrap two contentious rules meant to rein in conflicted investment advice and payday lenders once President-elect Donald Trump takes office.

Era of Low Interest Rates Hammers Millions of Pensions Around World

Related Link: 

Central-bank moves are pulling down returns for government-run funds, making it difficult to meet mounting obligations to workers and retirees. Low rates are exacerbating existing cash problems.

Retirement Policy Under Trump? Unclear, but There Are Clues

Related Link: 

Donald Trump hasn’t said a lot about Social Security funding or other retirement-savings policies, but his few comments—along with congressional Republicans’ proposals—provide some insight on what to expect.

Syndicate content